MoneyWorks4Me

Vivimed Labs informs about approval of products

16 Apr 2021 Evaluate

Vivimed Labs has informed that it received approvals for the following 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site: Bilastine tablets 20mg under brand name FLUSTIN; Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI; and Paracetamol 12Smg/ Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..